Seres Therapeutics

MCRBNASDAQ
$0.769700
0.056.34%
Pre-Market: 5:22 AM EDT
15 minutes delayed

Seres Therapeutics (NASDAQ:MCRB) Stock Quotes, Forecast and News Summary

Seres Therapeutics Stock (NASDAQ: MCRB) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.2.55K / 4.84M
Day Range- - -
52 Wk Range0.54 - 5.29
Market Cap$116.57M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
47
Short Interest
21.11%
Days to Cover3.45
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jan
1
Mar
1
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Seres Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States....
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MCRB
ARMP

FAQ

Q

How do I buy Seres Therapeutics (MCRB) stock?

A

You can purchase shares of Seres Therapeutics (NASDAQ:MCRB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Seres Therapeutics (MCRB) competitors?

Q

What is the target price for Seres Therapeutics (MCRB) stock?

A

There is no analysis for Seres Therapeutics.

Q

What is the forecast for Seres Therapeutics (MCRB) stock?

A

Seres Therapeutics has a consensus price target of $8.78.

Q

Current stock price for Seres Therapeutics (MCRB)?

A

The stock price for Seres Therapeutics (NASDAQ: MCRB) is $0.7697 last updated Today at July 1, 2024 at 5:22 AM EDT.

Q

Does Seres Therapeutics (MCRB) pay a dividend?

A

There are no upcoming dividends for Seres Therapeutics.

Q

When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?

A

Seres Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Seres Therapeutics (MCRB) going to split?

A

There is no upcoming split for Seres Therapeutics.

Q

What sector and industry does Seres Therapeutics (MCRB) operate in?

A

Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch